XS0601相关论文
XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutane
Background XS0601, consisting of active ingredients (Chuangxiongol and paeoniflorin), has been shown to inhibit arterial......
XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutane
Background XS0601, consisting of active ingredients (Chuangxiongol and paeoniflorin), has been shown to inhibit arterial......
